Improved Cationic Lipid Formulations for In Vivo Gene Therapy

Annals of the New York Academy of Sciences

Volumn 772, Issue 1, 1995, Pages 126-139

  FELGNER, PHILIP L ^a   TSAI, YALI J ^a   SUKHU, LORETTA ^a   WHEELER, CARL J ^a   MANTHORPE, MARSTON ^a   MARSHALL, JOHN ^b   CHENG, SENG H ^b  

^a VICAL INC   (United States)

^b GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; CHOLESTEROL; LIPID; PLASMID DNA;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CYTOPLASM; ENHANCER REGION; GENE TARGETING; GENE THERAPY; HEART MUSCLE; MOUSE; NONHUMAN; PLASMID; PROMOTER REGION; REPORTER GENE; SKELETAL MUSCLE;

ANIMALIA;

EID: 0029553015     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1995.tb44738.x     Document Type: Article

References (51)

1. Lipofection: a novel highly efficient lipid mediated DNA transfection procedure
2. Cationic liposome mediated transfection
3. Cationic liposome‐mediated transfection
4. Particulate systems and polymers for in vitro and in vivo delivery of polynucleotides
5. Cationic liposome‐mediated transfection with lipofectin reagent
6. Intracellular delivery of nucleic acids and transcription factors using cationic liposomes
7. Cationic lipid mediated transfection in mammalian cells: “lipofection.”
8. Cationic lipid mediated delivery of polynucleotides
9. Lipofectin mediated RNA transfection
10. Lipofectamine reagent: a new, higher efficiency polycationic liposome transfection reagent
11. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine‐coated DNA
12. Regulation of gene expression in vivo by liposome mediated delivery of a purified transcription factor
13. Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes
14. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles
15. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells
16. A novel cationic liposome reagent for efficient transfection of mammalian cells
17. Effect of cationic cholesterol derivatives on gene transfer and protein kinase C. activity
18. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice
19. Direct gene transfer into mouse muscle in vivo
20. Cationic lipids for reporter gene and CFTR gene transfer to rat pulmonary epithelium
21. Systemic gene expression after intravenous DNA delivery into adult mice
22. In vivo gene delivery. Efficient transfection of T lymphocytes in adult mice
23. Aerosol gene delivery in vivo
24. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice
25. Implantation of genetically engineered fibroblasts into mice: implications for gene therapy
26. Long‐term in vivo expression of retrovirus‐mediated gene transfer in mouse fibroblast implants
27. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of a replication defective adenovirus
28. Heterologous protection against influenza by injection of DNA encoding a viral protein
29. A generic intron increases gene expression in transgenic mice
30. Effect on intron A from human cytomegalovirus (Towne) immediate early gene on heterologous expression in mammalian cells
31. New structures in complex formation between DNA and cationic liposomes visualized by freeze‐fracture electron microscopy
32. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action
33. Cytoplasmic expression of a reporter gene by co‐delivery of T7 RNA polymerase and T7 promoter sequence with cationic liposomes
34. Delivery of plasmid DNA into mammalian cell lines using pH‐sensitive liposomes: comparison with cationic liposomes
35. Fusion of liposomes containing a novel cationic lipid, N‐[2,3‐(dioleyloxy)propyl]‐N, N, N‐trimethylammonium: induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles
36. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
37. Increased gene expression after liposome‐mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury
38. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid mediated gen transfer
39. Non‐invasive liposome‐mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice
40. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy
41. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma
42. Direct gene transfer with DNA‐liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans
43. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses
44. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine
45. Gene therapy for cystic fibrosis using cationic liposomes mediated gene transfer: a phase I trial of safety and efficacy in the nasal airway
46. Immunotherapy for cancer by direct gene transfer into tumors: clinical protocol
47. Coupling of adenovirus to transferrin‐polylysine/DNA complexes greatly enhances receptor‐mediated gene delivery and expression of transfected genes
48. Stepwise dismantling of adenovirus 2 during entry into cells